To examine the potential role of LRRK2 kinase activity in DSS-induced colitis, we then investigated the impact of LRRK2-IN-1 treatment on colitis development in both LRRK2 KI mice and littermate controls using the DSS colitis model. This evidence concerns the gene LRRK2 and colitis.